Back to browse

EXP002582

Paper

Mechanisms of Nanoparticle-Mediated siRNA Transfection by Melittin-Derived Peptides (2013)

Peptide

p5RHH

Sequence: VLTTGLPALISWIRRRHRRHC

RNA

siRNA

All experiment fields

Experiment Id EXP002582
Paper Mechanisms of Nanoparticle-Mediated siRNA Transfection by Melittin-Derived Peptides
Peptide p5RHH
Delivery Success Class no
In Vivo Flag yes
Uptake Confirmed yes
Label Confidence high
In Vitro Functional Effect
Endosomal Escape Evidence yes
Peptide Concentration for animal experiments peptide and siRNA incubated at 10-fold higher concentration than in vitro formulation
Rna Concentration 1 mg/kg siRNA dose by tail-vein injection
Mixing Ratio peptide:siRNA 100:1
Formulation Format albumin-stabilized peptide/siRNA nanocomplex
Formulation Components p5RHH nanoparticles carrying Cy5.5-labeled scrambled siRNA
Size Nm 55.00
Zeta Mv
Model Scope in_vivo
Model Type in vivo tumor localization / biodistribution
Cell Lines Or Primary Cells
Animal Model transgenic mice with spontaneous ATLL tumors
Administration Route tail-vein injection; single 1 mg/kg dose; 24 h before sacrifice
Output Type in vivo tumor localization imaging
Output Value IVIS and confocal microscopy showed Cy5.5-siRNA signal localized to tumor periphery after systemic delivery; minimal liver/spleen uptake reported
Output Units
Output Notes delivery_success_class = 0 because this was in vivo localization/uptake imaging only with scrambled siRNA and no functional RNA knockdown or therapeutic effect. in_vivo_flag = 1 and uptake_confirmed = 1 because in vivo tumor siRNA localization was directly imaged.
Toxicity Notes No therapeutic toxicity analysis from this localization-only pilot experiment; scrambled siRNA was non-toxic in vitro
Curation Notes